Parametric Portfolio Associates’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$51.2M Buy
154,618
+10,307
+7% +$3.17M 0.03% 553
2021
Q4
$51.8M Sell
144,311
-4,634
-3% -$1.57M 0.03% 560
2021
Q3
$48.5M Buy
148,945
+9,309
+7% +$3.15M 0.03% 564
2021
Q2
$43.6M Buy
139,636
+560
+0.4% +$172K 0.02% 615
2021
Q1
$44.3M Buy
139,076
+4,324
+3% +$1.38M 0.03% 648
2020
Q4
$43.7M Sell
134,752
-117
-0.1% -$32.4K 0.03% 589
2020
Q3
$37.4M Buy
134,869
+4,748
+4% +$1.37M 0.03% 552
2020
Q2
$31.4M Buy
130,121
+37,172
+40% +$7.46M 0.02% 627
2020
Q1
$13.5M Buy
92,949
+4,021
+5% +$668K 0.01% 1026
2019
Q4
$15.2M Sell
88,928
-4,743
-5% -$879K 0.01% 1166
2019
Q3
$16.7M Sell
93,671
-14,472
-13% -$3.13M 0.01% 1059
2019
Q2
$28.2M Buy
108,143
+25,857
+31% +$6.86M 0.02% 704
2019
Q1
$23.5M Buy
82,286
+10,697
+15% +$3.56M 0.02% 795
2018
Q4
$23.3M Buy
71,589
+18,699
+35% +$6.5M 0.02% 712
2018
Q3
$23.8M Sell
52,890
-4,273
-7% -$1.68M 0.02% 785
2018
Q2
$23.4M Buy
57,163
+8,452
+17% +$3.06M 0.02% 745
2018
Q1
$14.2M Sell
48,711
-1,281
-3% -$325K 0.01% 1052
2017
Q4
$9.37M Buy
49,992
+4,295
+9% +$802K 0.01% 1375
2017
Q3
$7.71M Buy
45,697
+2,617
+6% +$396K 0.01% 1482
2017
Q2
$6.17M Buy
43,080
+79
+0.2% +$10.6K 0.01% 1583
2017
Q1
$5.38M Buy
43,001
+1,789
+4% +$207K 0.01% 1686
2016
Q4
$4.64M Sell
41,212
-3,692
-8% -$428K 0.01% 1728
2016
Q3
$5.77M Sell
44,904
-37,998
-46% -$4.55M 0.01% 1416
2016
Q2
$9.06M Sell
82,902
-28,863
-26% -$2.87M 0.01% 1008
2016
Q1
$10.6M Buy
111,765
+60,830
+119% +$5.13M 0.02% 894
2015
Q4
$4.6M Buy
50,935
+3,336
+7% +$283K 0.01% 1448
2015
Q3
$4.42M Buy
47,599
+5,141
+12% +$453K 0.01% 1220
2015
Q2
$2.79M Buy
42,458
+10,879
+34% +$723K 0.01% 1931
2015
Q1
$2.26M Buy
31,579
+9,122
+41% +$495K ﹤0.01% 2123
2014
Q4
$855K Buy
22,457
+5,898
+36% +$186K ﹤0.01% 2906
2014
Q3
$411K Buy
16,559
+3,505
+27% +$88.8K ﹤0.01% 3317
2014
Q2
$328K Sell
13,054
-116
-0.9% -$2.7K ﹤0.01% 3467
2014
Q1
$343K Buy
13,170
+355
+3% +$9.82K ﹤0.01% 3372
2013
Q4
$343K Buy
+12,815
New +$317K ﹤0.01% 3361

Other funds holding ABMD